Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Trials

MRD trials

The curated index is a sourced list of studies. Accruing is the live ClinicalTrials.gov set of studies that are recruiting or not yet recruiting. DYNAMIC-III is not in the curated index because it is registered in Australia and New Zealand, not with an NCT id.

Recruiting and not-yet-recruiting studies that use ctDNA, cfDNA, or MRD in eligibility, a treatment decision, or a primary or secondary endpoint, plus observational studies focused on that testing. 1123 studies from 2267 registry records. Hematologic trials that list MRD only as a secondary endpoint are listed separately. Last synced Nov 18, 2026, 2:04 PM EST.

  • GI · BiliaryNot yet recruitingPhase 3NCT07745296

    Investigating Precision Medicine in the Adjuvant Setting in Biliary Tract Cancer

    UNICANCER · Locations not reported · Updated 2026-08-04

  • GI · BiliaryRecruitingPhase 2NCT07359820

    A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement

    Elevar Therapeutics · 19 locations · Updated 2026-11-09

  • GI · BiliaryRecruitingPhase 2NCT06313203

    HAI-Floxuridine, or SIRT, Combined With Gemox For Patients With Intra-Hepatic Cholangiocarcinoma Not Amenable to Resection (TOMCAT)

    Oslo University Hospital · 1 locations · Updated 2026-02-02

  • GI · Biliary, PancreaticRecruitingPhase 1 / Phase 2NCT06730009

    Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients

    Medigen Biotechnology Corporation · 1 locations · Updated 2025-12-17

  • GI · BiliaryNot yet recruitingNot reportedObservationalNCT07830628

    Bile ctDNA Genomic Profiling and Concordance With Tumor Tissue in Biliary Tract Cancer

    CHA University · 1 locations · Updated 2026-10-13

  • GI · BiliaryRecruitingPhase 1NCT06302621

    Pemigatinib + Afatinib in Advanced Refractory Solid Tumors

    Massachusetts General Hospital · 1 locations · Updated 2026-09-23

  • GI · BiliaryNot yet recruitingNot reportedObservationalNCT07814586

    Prognostic Evaluation and Systematic Re-Assessment of Cholangiocarcinoma Therapy

    Karolinska University Hospital · Locations not reported · Updated 2026-09-11

  • GI · Liver / HCC, Biliary, PancreaticRecruitingNot applicableNCT05497531

    Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

    University of California, Irvine · 1 locations · Updated 2026-08-31

  • GI · Liver / HCC, BiliaryRecruitingNot reportedObservationalNCT06877637

    On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer

    Region Skane · 3 locations · Updated 2026-08-03

  • GI · BiliaryRecruitingPhase 1NCT06058663

    Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma

    Mayo Clinic · 1 locations · Updated 2026-05-13

  • GI · BiliaryRecruitingNot applicableNCT06125769

    LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA)

    Azienda Sanitaria Ospedaliera · 1 locations · Updated 2026-04-03

  • GI · BiliaryRecruitingNot reportedObservationalNCT07151118

    ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer

    CHA University · 1 locations · Updated 2026-03-18

  • GI · BiliaryRecruitingNot reportedObservationalNCT06648057

    Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

    CHA University · 1 locations · Updated 2026-03-18

  • GI · BiliaryRecruitingNot reportedObservationalNCT07142226

    Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC

    CHA University · 1 locations · Updated 2026-03-18

  • GI · BiliaryNot yet recruitingNot reportedObservationalNCT07454486

    TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort

    Aarhus University Hospital · 1 locations · Updated 2026-03-06

  • GI · Biliary, Pancreatic, ColorectalRecruitingNot reportedObservationalNCT06202131

    Use of Ctdna in Patients With Gastrointestinal Tract Tumors

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS · 1 locations · Updated 2025-09-02

  • GI · Liver / HCC, Biliary, PancreaticRecruitingNot reportedObservationalNCT06139042

    Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers

    Second Affiliated Hospital, Zhejiang University, School of Medicine · 1 locations · Updated 2025-02-10

  • GI · BiliaryRecruitingNot reportedObservationalNCT06653127

    Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence Surveillance

    Tongji Hospital · 1 locations · Updated 2024-12-30

  • GI · BiliaryRecruitingNot applicableNCT06098547

    LIver Transplantation for Non-Resectable Intrahepatic CholAngiocarcinoma (LIRICA)

    Azienda Sanitaria Ospedaliera · 1 locations · Updated 2024-01-24

Status can change after this sync. The curated list is the other view on this page. Evidence holds the published results.